OnCore Login
network member

Michigan State University

About Network Member

Enrollment Closed

BTCRC-BRE16-042

A Phase II Study of Pembrolizumab Plus Fulvestrant in Hormone Receptor Positive, HER-2 Negative Advanced/Metastatic Breast Cancer Patients: Big Ten Cancer Research Consortium BTCRC-BRE16-042
Nancy Chan
Cancer areas:Breast
Fred & Pamela Buffett Cancer Center
Michigan State University
New York University Cancer Institute
Rutgers Cancer Institute of New Jersey
University of Wisconsin Carbone Cancer Center
Learn More
See clinicaltrials.gov
  • 7676 Interactive Way, Suite 120, Indianapolis, IN 46278